PMID- 32878057 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201028 IS - 2077-0383 (Print) IS - 2077-0383 (Electronic) IS - 2077-0383 (Linking) VI - 9 IP - 9 DP - 2020 Aug 31 TI - Individuals with Peripheral Artery Disease (PAD) and Type 1 Diabetes Are More Likely to Undergo Limb Amputation than Those with PAD and Type 2 Diabetes. LID - 10.3390/jcm9092809 [doi] LID - 2809 AB - BACKGROUND: Limited data exist comparing how type 1 diabetes mellitus (DM) and type 2 DM may have differential effects on peripheral artery disease (PAD) severity. We aimed to study the association of type of DM with the procedure utilized in hospitalizations with a diagnosis of PAD. METHODS: We used the national inpatient sample databases from 2003 to 2014 to identify hospitalizations with a diagnosis of PAD and type 1 or type 2 DM. Logistic regression was utilized to evaluate the association between type of DM and procedure utilized (amputation-overall, major, endovascular revascularization, surgical revascularization). RESULTS: We identified 14,012,860 hospitalizations with PAD diagnosis and DM, 5.6% (n = 784,720) had type 1 DM. The patients with type 1 DM were more likely to present with chronic limb-threatening ischemia (CLTI) (45.2% vs. 32.0%), ulcer (25.9% vs. 17.7%), or complicated ulcer (16.6% vs. 10.5%) (all p < 0.001) when compared to those with type 2 DM. Type 1 DM was independently and significantly associated with more amputation procedures (adjusted odds ratio = 1.12, 95% confidence interval [CI] I 1.08 to 1.16, p < 0.001). Overall, in-hospital mortality did not differ between the individuals with type 1 and type 2 DM. The overall mean (95% CI) length of stay (in days) was 6.6 (6.5 to 6.6) and was significantly higher for type 1 DM (7.8 [7.7 to 8.0]) when compared to those with type 2 DM (6.5 [6.4 to 6.6]). CONCLUSION: We observed that individuals with PAD and type 1 DM were more likely to present with CLTI and ulcer and undergo amputation when compared to those with PAD and type 2 diabetes. Further studies are needed to better understand the underlying mechanisms behind these findings and to identify novel interventions to reduce the risk of amputation in patients with type 1 DM. FAU - Jain, Nidhi AU - Jain N AD - Torrance Memorial Physician Network, Torrance, CA 90505, USA. FAU - Agarwal, Manyoo A AU - Agarwal MA AD - Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA. AD - Division of Cardiovascular Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA. FAU - Jalal, Diana AU - Jalal D AUID- ORCID: 0000-0002-1975-8650 AD - Division of Nephrology, Department of Medicine, Carver College of Medicine, University of Iowa, Iowa, IA 52242, USA. FAU - Dokun, Ayotunde O AU - Dokun AO AD - Division of Endocrinology and Metabolism, Department of Medicine, Carver College of Medicine, University of Iowa, Iowa, IA 52242, USA. LA - eng GR - R01 HL130399/NH/NIH HHS/United States PT - Journal Article DEP - 20200831 PL - Switzerland TA - J Clin Med JT - Journal of clinical medicine JID - 101606588 PMC - PMC7563979 OTO - NOTNLM OT - HCUP OT - NIS OT - amputation OT - outcomes OT - peripheral artery disease OT - procedure OT - type 1 diabetes OT - type 2 diabetes COIS- The authors declare no conflict of interest. EDAT- 2020/09/04 06:00 MHDA- 2020/09/04 06:01 PMCR- 2020/08/31 CRDT- 2020/09/04 06:00 PHST- 2020/07/13 00:00 [received] PHST- 2020/08/16 00:00 [revised] PHST- 2020/08/28 00:00 [accepted] PHST- 2020/09/04 06:00 [entrez] PHST- 2020/09/04 06:00 [pubmed] PHST- 2020/09/04 06:01 [medline] PHST- 2020/08/31 00:00 [pmc-release] AID - jcm9092809 [pii] AID - jcm-09-02809 [pii] AID - 10.3390/jcm9092809 [doi] PST - epublish SO - J Clin Med. 2020 Aug 31;9(9):2809. doi: 10.3390/jcm9092809.